share_log

HC Wainwright & Co. Reiterates Buy on Pacira BioSciences, Maintains $57 Price Target

Benzinga ·  May 8 15:25

HC Wainwright & Co. analyst Oren Livnat reiterates Pacira BioSciences (NASDAQ:PCRX) with a Buy and maintains $57 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment